MedTrace Logo

Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection

NCT05211011 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 226

Last updated 2022-01-27

No results posted yet for this study

Summary

The PROOF Study is an open prospective interventional non-randomized study which aim is to determine the outcome / effect and safety of fosfomycin in patients with hip, knee or shoulder PJI.

Conditions

  • Prosthetic Joint Infection

Interventions

DRUG

Fosfomycin

Infectofos 5 g

Sponsors & Collaborators

  • Pro-Implant Foundation

    collaborator OTHER

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Andrej Trampuz, PD Dr · Charite University, Berlin, Germany

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-23
Primary Completion
2022-04-30
Completion
2023-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05211011 on ClinicalTrials.gov